Skip Navigation LinksHome > June 2012 - Volume 7 - Issue 6 > Drug Reference Index
Journal of Thoracic Oncology:
doi: 10.1097/JTO.0b013e318253da12
Submitted Abstracts

Drug Reference Index

Free Access

Azacitidine:86PD

Bevacizumab: 80O, 169PD, 197P, 203P, 204P

Carboplatin: 157P, 190P, 192P, 195P, 200P, 211P, 221P

Cisplatin: 89PD, 136O, 145P, 157P, 174PD, 192P, 196P, 197P, 202P, 212P, 219P, 226P, 227O

Crizotinib: 76O, 87PD, 109P, 175P, 176P, 177P, 251P

Cyclophosphamide : 226P

Dacomitinib: 165O, 166O, 182P

Dasatinib: 86PD

Debio0932: 196P

Dendritic cells vaccine: 98P

Denosumab: 168O

Docetaxel: 136O, 145P, 167O, 174PD, 196P, 200P

Doxorubicine : 226P

EC145: 172PD

EC20: 172PD

Enobosarm: 187P, 188P

Erlotinib: 80O, 163O, 165O, 166O, 167O, 171PD, 173PD, 182P, 183P, 184P, 185P, 193P, 194P, 198P

Erythropoietin: 101P

Etoposide: 157P, 174PD, 212P, 219P, 226P

Gefitinib: 95P, 126P, 173PD, 185P

Gemcitabine: 157P, 174PD, 190P, 196P, 202P

Irinotecan: 221P

Paclitaxel: 195P, 211P

Pemetrexed : 125P, 192P, 196P, 197P, 198P, 199P, 200P, 201P, 202P, 204P

RAD001: 211P

Raltitrexed: 227O

SOM230: 211P

Sorafenib: 233P

Temozolomide: 193P

Topotecan: 221P

Vincristine: 226P

Vinorelbine: 89PD, 126P, 145P, 174PD

Zoledronic acid: 168O, 215P

© 2012International Association for the Study of Lung Cancer

Login

Article Tools

Share

Other Ways to Connect

Twitter
twitter.com/JTOonline

 



Visit JTO.org on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.